Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia

A proportion of people infected with SARS-CoV-2 develop moderate or severe COVID-19, with an increased risk of thromboembolic complications. The inflammatory response to SARS-CoV-2 infection can cause an acute-phase response and endothelial dysfunction, which contribute to COVID-19-associated coagul...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent, Jean-Louis, Levi, Marcel, Hunt, Beverley J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616572/
https://www.ncbi.nlm.nih.gov/pubmed/34838161
http://dx.doi.org/10.1016/S2213-2600(21)00455-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616572/
https://www.ncbi.nlm.nih.gov/pubmed/34838161
http://dx.doi.org/10.1016/S2213-2600(21)00455-0

Ejemplares similares